Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Bodal Chemicals Ltd

BODALCHEM
NSE
67.03
2.67%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Bodal Chemicals Ltd

BODALCHEM
NSE
67.03
2.67%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
844Cr
Close
Close Price
67.03
Industry
Industry
Dyes & Pigments
PE
Price To Earnings
27.93
PS
Price To Sales
0.45
Revenue
Revenue
1,875Cr
Rev Gr TTM
Revenue Growth TTM
11.11%
PAT Gr TTM
PAT Growth TTM
400.99%
Peer Comparison
How does BODALCHEM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
BODALCHEM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
390332330339394422429443451454480490
Growth YoY
Revenue Growth YoY%
-34.8-27.6-17.85.61.026.929.931.014.67.612.110.4
Expenses
ExpensesCr
363310307315368388396399404407457468
Operating Profit
Operating ProfitCr
272223242534334547482322
OPM
OPM%
6.96.77.17.06.48.27.610.010.510.54.84.5
Other Income
Other IncomeCr
49655251242015
Interest Expense
Interest ExpenseCr
121313121621202021222019
Depreciation
DepreciationCr
151514151717171717181717
PBT
PBTCr
5322-2-118121360
Tax
TaxCr
2101-4013-3300
PAT
PATCr
32112-105151060
Growth YoY
PAT Growth YoY%
-90.3-90.2-87.9-59.7-27.4-153.4-119.3453.1610.8907.62,595.8-95.6
NPM
NPM%
0.70.70.40.30.5-0.3-0.11.23.22.11.30.1
EPS
EPS
0.20.20.10.10.2-0.10.00.41.10.80.50.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,0459101,2341,1421,4241,3751,2262,0551,5741,3951,7451,875
Growth
Revenue Growth%
8.9-12.935.7-7.524.6-3.4-10.867.6-23.4-11.425.17.5
Expenses
ExpensesCr
8617601,0089481,1871,2371,1401,8351,4411,2841,5781,735
Operating Profit
Operating ProfitCr
18415022619423613887220133111167140
OPM
OPM%
17.616.518.317.016.610.07.110.78.57.99.67.5
Other Income
Other IncomeCr
519159131016-2129241
Interest Expense
Interest ExpenseCr
271295919172941548282
Depreciation
DepreciationCr
222629122128304753606969
PBT
PBTCr
139131204186219101551425151930
Tax
TaxCr
474571627715164313-210
PAT
PATCr
92861331251428640993861930
Growth
PAT Growth%
204.3-6.354.6-6.314.1-39.5-53.8148.1-61.5-83.0186.063.5
NPM
NPM%
8.89.410.810.910.06.33.24.82.40.51.11.6
EPS
EPS
8.47.912.210.611.67.13.38.83.00.51.52.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
222222242424242525252525
Reserves
ReservesCr
1352133416738058649571,0281,0531,0571,0801,097
Current Liabilities
Current LiabilitiesCr
254259316348411495610804621694767768
Non Current Liabilities
Non Current LiabilitiesCr
991626295838159266422511481423
Total Liabilities
Total LiabilitiesCr
5345107071,0751,2991,4711,7552,1222,1212,2882,3532,313
Current Assets
Current AssetsCr
3233074055376167588711,131851813898873
Non Current Assets
Non Current AssetsCr
2112023025386837138859921,2701,4741,4551,440
Total Assets
Total AssetsCr
5345107071,0751,2991,4711,7552,1222,1212,2882,3532,313

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
198131104718610-13-14290204114
Investing Cash Flow
Investing Cash FlowCr
-35-23-68-256-128-81-168-170-310-262-37
Financing Cash Flow
Financing Cash FlowCr
-162-109-23236-51761781813381-73
Net Cash Flow
Net Cash FlowCr
0-113-1375-3-38243
Free Cash Flow
Free Cash FlowCr
16210745-22138-43-191-170-29-2969
CFO To PAT
CFO To PAT%
215.4152.678.05.7130.811.1-32.7-13.7762.23,157.3615.0
CFO To EBITDA
CFO To EBITDA%
107.487.645.93.678.86.9-15.0-6.2217.4184.568.1

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3687991,7481,4861,5495171,1021,235725922737
Price To Earnings
Price To Earnings
4.09.413.212.110.85.926.311.819.1143.739.8
Price To Sales
Price To Sales
0.30.91.41.31.10.40.90.60.50.70.4
Price To Book
Price To Book
2.43.44.82.11.90.61.11.20.70.80.7
EV To EBITDA
EV To EBITDA
3.16.38.38.57.25.517.88.611.016.29.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.137.335.438.237.835.835.244.043.149.849.2
OPM
OPM%
17.616.518.317.016.610.07.110.78.57.99.6
NPM
NPM%
8.89.410.810.910.06.33.24.82.40.51.1
ROCE
ROCE%
45.637.841.521.922.910.45.09.95.03.05.0
ROE
ROE%
58.636.636.617.917.19.74.09.43.50.61.7
ROA
ROA%
17.216.918.811.610.95.82.34.71.80.30.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Bodal Chemicals Limited is India’s largest integrated manufacturer of **dyestuffs** and **dye intermediates**, currently undergoing a strategic transformation into a diversified specialty chemicals powerhouse. With a "foundational to global" integration strategy, the company operates a vertically integrated business model that spans from basic chemicals to high-performance colorants and benzene derivatives. ### **The Integrated Value Chain: "Foundational to Global"** Bodal’s competitive moat is built on a high degree of backward and forward integration. Approximately **40%** of basic chemicals and **40%** of dye intermediates are consumed captively, ensuring raw material security and cost-efficiency. | Vertical | Key Products | Strategic Role | FY25 Revenue Share | |:---|:---|:---|:---| | **Dye Intermediates** | Vinyl Sulphone, H-Acid, Gamma Acid, K-Acid | Operational backbone; **40%** captive consumption for dyestuffs. | **39%** | | **Dyestuffs** | Reactive, Acid, and Direct Dyes (175+ products) | Forward integration serving textile (**80%** of demand), leather, and paper. | **29%** | | **Chlor-Alkali** | Caustic Soda, Chlorine, Hydrogen, TCCA | Diversified revenue stream; serves water treatment and hygiene. | **20%** | | **Basic Chemicals** | Sulphuric Acid, Thionyl Chloride, Acetanilide | Backward integration; **40-50%** captive use. | **5%** | | **Benzene Downstream** | MCB, PNCB, ONCB, MNCB, DCB | New high-value specialty segment for agrochemicals and pharma. | **1% (Scaling)** | --- ### **Manufacturing Footprint & Technological Infrastructure** Bodal operates **8 active manufacturing facilities** primarily located in India’s western chemical belt, providing logistical advantages via proximity to major seaports (Mundra, Hazira, Nhava Sheva). * **Total Capacity:** Approximately **470,000 MTPA** across all segments. * **Saykha Greenfield Facility:** A **₹540 crore** state-of-the-art plant with **63,000 MTPA** capacity for Benzene derivatives. It features world-class German **Adiabatic Nitration** and Swiss **Continuous Crystallisation** technologies. * **Strategic Consolidation:** In **2024-25**, the company permanently decommissioned legacy units at **Vatva (Units I, II, and III)** to optimize costs and shift production to more efficient, automated facilities in **Vadodara** and **Kosi**. * **R&D and Distribution:** Operates **2 In-house R&D labs** in Vadodara and a global distribution network of **10 Depots** (6 in India, 1 each in China, Turkey, Bangladesh, and Indonesia). --- ### **Strategic Realignment & Asset Optimization** The company is actively pivoting from volume-driven intermediates to value-added specialty chemicals while rationalizing its balance sheet. * **Asset Monetization:** In **February 2026**, the board approved the sale of **40 acres** of surplus land at Unit-12. The buyers will establish units to consume byproduct **Chlorine** and **Hydrogen**, creating a circular ecosystem and ensuring uninterrupted production. * **Product Diversification:** Entry into **TCCA (Trichloroisocyanuric Acid)** for water treatment. Profitability is expected to rise following the imposition of a **5-year anti-dumping duty** on Chinese imports in **March 2025**, potentially adding **₹50-₹60 crore** to annual turnover. * **Capital Infusion:** Approved the issuance of **1,00,00,000 share warrants** at **₹85.60** per warrant (totaling **₹85.60 crore**) to non-promoters in **April 2024** to fund working capital and debt reduction. * **Corporate Streamlining:** Completed the merger of **SPS Processors** and **Trion Chemicals** into Bodal Chemicals to simplify the corporate structure. --- ### **Financial Performance & Segment Analysis** While the company has faced headwinds from global demand suppression and high interest liabilities, **9MFY26** showed a recovery trend with **12% YoY revenue growth**. **Consolidated Financial Summary:** | Metric (₹ Crore) | 9MFY26 | FY25 | FY24 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **1,463.3** | **1,756.7** | **1,419.4** | | **EBITDA** | **131.7** | **170.7** | **119.5** | | **PAT** | **15.8** | **18.5** | **6.5** | | **EBITDA Margin** | **9.0%** | **9.7%** | **8.4%** | **Key Segment Highlights:** * **Chlor-Alkali:** Revenue reached **₹255.3 crore** for **9MFY26**. This follows a volatile **FY24** where revenue declined **18%** despite a **17% volume increase** due to crashing Caustic Soda prices. * **Benzene Downstream:** Estimated revenue potential of **₹320 crore** at optimum utilization with **12% to 15%** EBITDA margins. * **Exceptional Items:** Recognized profits of **₹10.66 crore** and **₹7.23 crore** in **FY26** from the sale of inoperative Vatva units. --- ### **Global Subsidiary Network & Market Reach** Bodal serves over **600 customers** across **35+ countries**, with exports contributing approximately **28%** of total revenue. * **Sener Boya (Turkey):** A regional hub for Europe; currently navigating **hyperinflationary accounting (Ind AS 29)** which resulted in a **₹1.45 crore** debit in mid-2025. * **PT Bodal Indonesia:** A high-growth marketing arm reporting **64% YoY** revenue growth. * **BCTPL (India):** Domestic trading arm reinitiated in **FY25** for opportunity-led arbitrage. * **Bodal China & Bodal Bangla:** Strategic outposts serving the world's largest chemical and textile hubs. --- ### **Sustainability, ESG & Compliance** Bodal is committed to high environmental standards, essential for maintaining its status as a preferred global supplier. * **Environmental Tech:** Operates **Zero Liquid Discharge (ZLD)** systems; features the world’s first **Brine Treatment Plant** using AMBC technology at Unit-VII. * **Energy Efficiency:** Awarded the **National Energy Conservation Award 2024** (Second Prize) in the Chlor-Alkali sector. * **Certifications:** ISO 9001, 14001, 45001; **Bluesign** System Partner; GOTS, ZDHC, and BEHIVE certified. * **Supply Chain:** Successfully shifted from China-dependency to **~90% local sourcing** within Gujarat. --- ### **Risk Profile & Mitigation Strategies** The company manages a complex risk landscape through a formal Risk Management Committee. * **Macro & Geopolitical:** Exposure to hyperinflation in Turkey and political instability in Bangladesh. * **Financial Leverage:** Total debt stood at **₹896.97 crore** (March 2024). Credit ratings were adjusted to **IND BBB+/Negative** due to performance deterioration and high capex-related interest costs (**~₹3 crore/month**). * **Regulatory & Labor:** The **New Labour Code (Nov 2025)** increased gratuity liabilities by **₹1.8 crore**. Environmental compliance costs typically range between **1%–2%** of sales. * **Commodity Volatility:** Susceptibility to price swings in **Aniline oil, Naphthalene, and Sulphur**. **Mitigation Table:** | Risk Factor | Mitigation Action | | :--- | :--- | | **Resource Scarcity** | **5 MW** Co-generation and **1.73 MW** waste heat recovery plants. | | **Chinese Competition** | Secured **Anti-Dumping Duty** on TCCA imports (March 2025). | | **Safety Risks** | Implementation of **HIRA** and **Quantitative Risk Assessment** for toxic chemicals. | | **Currency Risk** | Use of derivative forward contracts strictly for hedging **USD/EURO** exposure. |